✦ LIBER ✦

81 Catumaxomab: a causal therapy for malignant ascites

✍ Scribed by M. Essing; R. Linke; D. Seimetz; A. Klein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Catumaxomab beneficial for patients with

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

The trifunctional antibody catumaxomab i

✍ Ströhlein, Michael A; Heiss, Markus M 📂 Article 📅 2010 🏛 Future Medicine 🌐 English ⚖ 616 KB

First patient treated with a re-challeng

✍ Klaus Pietzner, Michael Jäger, Alexandra Schoberth, Gülten Oskay-Özcelik, Marc K 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 326 KB

Regression of liver metastases after tre

✍ Fausto Petrelli, Karen Borgonovo, Veronica Lonati, Stefano Elia… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

6507 Catumaxomab treatment in gastric-ca

✍ Heiss, M.; Linke, R.; Friccius-Quecke, H.; Klein, A.; Hennig, M.; Lindhofer, H.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

1312 Catumaxomab therapy eliminates puta

✍ H. Lindhofer; A. Schoberth; D. Pelster; J. Hess; J. Herold; M. Jäger 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB